Intuitive Surgical Inc ISRG
Intuitive Surgical Inc scores excellent on business quality (8.8 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Intuitive Surgical Inc does
Intuitive Surgical makes money by selling advanced robotic surgical systems, instruments, and accessories to hospitals and healthcare providers. Revenue is driven by high-margin recurring tool sales and procedure volumes.
- What it does best
Intuitive dominates robotic surgery through its massive installed base of systems and unmatched surgeon familiarity. With a gross margin of 66.7%, it easily outperforms peers like ABT at 56.8%, protected by immense switching costs in hospital operating rooms.
- The main risk
The primary threat is extreme valuation pressure. Trading well above intrinsic value at a price of 391.95 against an intrinsic value of 333.90, any minor slowdown in procedure growth risks triggering a sharp multiple contraction.
Quality, check by check
Scored against its own industry, from company filings.
Operating margins sit at a stellar 31.3% with an FCF margin in the top quartile of its sector at the 88th percentile. This business scales efficiently, turning revenue growth directly into cash.
High switching costs lock in hospitals and surgeons who train exclusively on its platform. It sits in the top decile of its sector for revenue growth at the 90th percentile, making new market entrants exceedingly rare.
Revenue is growing at 20.5% annually, accelerating rapidly from past historical periods. Procedure adoption across international markets powers this robust expansion.
Zero total debt and $6.0B in cash create an unassailable fortress balance sheet. Free cash flow surged to $3.2B, getting noticeably stronger year over year.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
No open market buys or unplanned sales by executives or directors.
Our sealed record on ISRG
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Intuitive Surgical Inc scores excellent on the Cluenex quality check (8.8 of 10), measured against its own industry. Profitability is strong, moat strong, growth fast and financial health strong.
In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.
Oct 20, 2026, after the close.
See ISRG today
- Today's verdict on ISRG, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Intuitive Surgical Inc (ISRG)”, https://cluenex.com/stocks/isrg/, data as of Oct 10, 2026.